Age, Race, and At-Risk Drinking in an HIV-infected U.S. Military Cohort
Overview
Authors
Affiliations
Introduction: There is a high prevalence of at-risk drinking in the U.S. military. Among HIV-infected individuals, alcohol abuse confers additional risk for adverse health outcomes. In the military, however, the characteristics of HIV-infected individuals who engage in high-risk drinking are not well defined. The purpose of this study was to assess risk factors associated with at-risk drinking in an HIV-positive longitudinal cohort of DoD beneficiaries.
Materials And Methods: Annual prevalence of at-risk drinking was calculated for members of the U.S. Military HIV Natural History Study who initiated highly active antiretroviral therapy (HAART) during or after January 2006 through May 2014; each participant completed at least one self-reported alcohol survey within a year of HAART initiation. Univariate and multivariable logistic regression was used to analyze factors associated with at-risk drinking.
Results: Sixty-six percent of subjects (495/752) reported at-risk drinking on at least one survey after HAART initiation. At-risk drinkers were more likely to be Active Duty compared to Retired (OR 0.65 95% CI [0.46, 0.92]). In multivariate models, Caucasian race (OR 3.30 95% CI [2.31, 4.71]); Hispanic/other race (OR 2.17 95% CI [1.51, 3.14]) and younger age (OR 0.61 per 10 years older, [95%CI 0.49, 0.75]) were significantly associated with at-risk drinking. Single relationship status (OR 1.51 95% CI [1.08, 2.13]) was also associated with at-risk drinking.
Conclusions: Consistent with general alcohol consumption patterns in the military, we found a high prevalence of at-risk drinking among individuals with HIV infection, which was associated most closely with young, non-African Americans. Targeting interventions toward this group will be important to reduce at-risk drinking and its potential for HIV-related complications.
Olapeju B, Hendrickson Z, Shanahan P, Mushtaq O, Ahmed A Front Public Health. 2024; 12:1324663.
PMID: 38454988 PMC: 10917956. DOI: 10.3389/fpubh.2024.1324663.
Noiman A, Esber A, Wang X, Bahemana E, Adamu Y, Iroezindu M Sci Rep. 2022; 12(1):1196.
PMID: 35075147 PMC: 8786968. DOI: 10.1038/s41598-022-04866-z.
Wood S, Won S, Hsieh H, Lalani T, Kronmann K, Maves R Open Forum Infect Dis. 2021; 8(3):ofab076.
PMID: 33738323 PMC: 7953661. DOI: 10.1093/ofid/ofab076.